At SNOMED International’s recent October Business Meetings held in London, the organization’s governance bodies enacted a decision to extend the core of SNOMED CT’s...
Hexion Holdings Corporation announced that as a result of its ongoing strategic review it has entered into a definitive agreement to sell its epoxy-based...
Lysogene, a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced that it has secured a €4.3 million non-dilutive financing...
Gynov ("the Company"), a French company that designs, manufactures and markets innovative nutritional supplements, Food for Special Medical Purposes (DADFMS) and medical devices for...
CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...
